Hemostasis clinical trials

Explore recruiting hemostasis clinical trials.

Recruiting hemostasis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hemostasis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized Study of Andexanet Alfa Compared to Usual Care in Patients Receiving a Factor Xa Inhibitor who Require Urgent Surgery or Procedure (ANNEXA-RS)

France, Portugal, Spain, Bulgaria, Slovakia, Denmark +13 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide parallel-group open randomized clinical trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

TAK-330-3001 - A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial with Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of TAK-330 for the Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation in Patients Requiring Urgent Surgery/Invasive Procedure

Netherlands, Spain, Austria, Germany, France, Belgium +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

FAMODREP : Interest of Famotidine in Reducing Endothelial Expression of P-selectin in Children With Sickle Cell Disease: Pilot Study, Single-center, Prospective, Non-comparative

France

Therapeutic use (Phase IV) EU CTIS Study details

Effect of Tofacitinib on coagulation and platelet function, and its role in thromboembolic events

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Rapid intravenous infusion of 10 and 22 degrees Celcius Ringer's lactate in healthy volunteers and its effects on circulation and hemostasis - a randomized crossover trial

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

Hemostasis trials by city

Hemostasis in Toronto Hemostasis in Vancouver Hemostasis in Montreal Hemostasis in Calgary Hemostasis in Edmonton Hemostasis in Ottawa Hemostasis in Winnipeg Hemostasis in Quebec City Hemostasis in Hamilton Hemostasis in Kitchener Hemostasis in London Hemostasis in Halifax Hemostasis in New York Hemostasis in Los Angeles Hemostasis in Chicago Hemostasis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease